JP
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
T-SPOT.TB
T-SPOT.TB
TB.300
The T-SPOT.TB test is designed for the detection of effector T cells that respond to stimulation by antigens specific for M. tuberculosis. The test enumerates individual activated TB-specific T cells. It is suitable for use with all patients at risk of LTBI or suspected of having TB disease, regardless of age, sex, ethnicity, therapy or immune status.1
| Feature | Specification |
|---|---|
| Application | 結核 |
| Brand | T-SPOT |
| Technology | ELISPOT |
Product variant
For in vitro diagnostic use. This product is only available where licensed in accordance with law. Please contact your local representative for availability.
T-SPOT.TB
TB.300
T-SPOT.TB
Product information
Overview
The T-SPOT.TB test is an in vitro diagnostic test for the detection of effector T cells that respond to stimulation by Mycobacterium tuberculosis antigens and is intended for use as an aid in the diagnosis of tuberculosis (TB) infection. The T-SPOT.TB test is a simplified enzyme-linked immunospot (ELISPOT) method which enumerates individual TB-specific activated effector T cells.
The kit contains:
- 1x T-SPOT test plate
- 2x vial Panel A
- 2x vial Panel B
- 2x vial PHA control
- 1x vial Conjugate solution
- 1x bottle Substrate solution
1Oxford Immunotec T-SPOT.TB Package Insert PI-TB-IVD-UK-v7. Abingdon, UK. September 2024.
Key features
The T-SPOT.TB test is designed for the detection of effector T cells that respond to stimulation by antigens specific for M. tuberculosis. The test enumerates individual activated TB-specific T cells. It is suitable for use with all patients at risk of LTBI or suspected of having TB disease, regardless of age, sex, ethnicity, therapy or immune status.1
Specifications
| Application |
Tuberculosis
|
|---|---|
| Brand |
T-SPOT
|
| Format |
96 well plate
|
| Regulatory Status |
CE-IVD marked
|
| Sample Type |
Whole blood
|
| Storage Conditions |
Store all components of the kit at 2-8 °C. Avoid prolonged exposure of the Substrate solution to light.
|
| Technology |
ELISPOT
|
| Unit Size |
24 tests/kit
|
Resources
Are you looking for resources, click on the resource type to explore further.
Flyer
A study analyzed pediatric samples to increase the IGRA reliability metrics in the pediatric populations
Flyer
High reproducibility of the interferon-gamma release assay T-SPOT.TB in serial testing.
Flyer
IGRAs are affected by immunosuppressive therapy, but the T-SPOT.TB test may be less affected
Case Study
The Importance of TB testing in the Immunosuppressed
This case study discusses the critical need for tuberculosis (TB) testing in immunosuppressed individuals, particularly in low...
How can we help you?
We are here to answer your questions.
